D. Mijakoski (Skopje, North Macedonia), R. Khanduri (Dehradun (Uttarakhand), India)
Relationship between emphysema extent and pulmonary function test in chronic obstructive pulmonary disease
M. Calheiros Barbosa Cabral (Lisboa, Portugal), J. Veiga (Lisboa, Portugal), D. Maia (Lisboa, Portugal), I. Gonçalves (Lisboa, Portugal), A. Mineiro (Lisboa, Portugal), S. Coelho (Lisboa, Portugal), P. Cravo (Lisboa, Portugal), L. Figueiredo (Lisboa, Portugal), J. Cardoso (Lisboa, Portugal)
|   |
Chronic obstructive pulmonary disease with preserved lung function, severe hypoxemia and emphysema
V. Danielo (Strasbourg, France), B. Coiffard (Marseille, France), M. Riou (Strasbourg, France), B. Renaud Picard (Strasbourg, France), M. Canuet (Strasbourg, France), R. Kessler (Strasbourg, France)
| |
Variation of maximal respiratory static pressures in different COPD severity group
F. Yangui (La Marsa, Tunisia), K. Chaabi (La Marsa, Tunisia), H. Cherif (La Marsa, Tunisia), S. Debbiche (La Marsa, Tunisia), M. Triki (La Marsa, Tunisia), I. Ktif (La Marsa, Tunisia), M. Charfi (La Marsa, Tunisia)
| |
ASSOCIATION BETWEEN NEUTROPHIL AND PLATELET TO LYMPHOCYTE RATIO AND DISEASE SEVERITY IN STABLE COPD
F. Perrotta (Campobasso, Italy), V. D'Agnano (Naples, Italy), M. Mollica (Naples, Italy), A. Costigliola (Naples, Italy), F. Cerqua (Naples, Italy), A. Bianco (Naples, Italy), B. Moncharmont (Campobasso, Italy)
| |
Spirometry and cardiopulmonary exercise test in lung resection surgery
N. Ben Salah (Tunis, Tunisia), H. Mrassi (Tunis, Tunisia), H. Blibech (Tunis, Tunisia), H. Snen (Tunis, Tunisia), L. Kaabi (Tunis, Tunisia), D. Belkhir (Tunis, Tunisia), A. Zaafouri (Tunis, Tunisia), N. Mehiri (Tunis, Tunisia), B. Louzir (Tunis, Tunisia)
| |
The change of the activity of the blood-salivary barrier (BSB) in patients with COPD
S. Soodaeva (Moscow, Russian Federation), N. Kubysheva (Kazan, Russian Federation), . Klimanov (Moscow, Russian Federation), . Nikitina (Moscow, Russian Federation), . Popova (Moscow, Russian Federation), T. Li (Moscow, Russian Federation), . Novoselov (Pushchino, Russian Federation)
| |
Can reversibility determine clinical course in patients with COPD?
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), N. Tsymbaliuk (Vinnitsya, Ukraine), A. Sidorov (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), M. Shostatska (Vinnitsya, Ukraine)
| |
Study over chronic obstructive pulmonary disease patients with hypercapnic respiratory failure
G. Jimborean (Targu Mures, Romania), E. Ianosi (Targu Mures , Romania), L. Mathe (Targu Mures , Romania), M. Szatmary (Targu Mures , Romania)
| |
“Smoking” vs “non-smoking” COPD: how dramatic is the difference?
K. Dmytriiev (Vinnitsya, Ukraine), Y. Mostovoy (Vinnitsya, Ukraine), N. Slepchenko (Vinnitsya, Ukraine), N. Tsymbaliuk (Vinnitsya, Ukraine), A. Sidorov (Vinnitsya, Ukraine), D. Dmytriiev (Vinnitsya, Ukraine), M. Shostatska (Vinnitsya, Ukraine)
| |
Telemonitoring in outpatients with COPD: a retrospective analysis of the effect on exacerbation rate, hospital admission and overall healthcare consumption using myCOPDcoach
M. de Roos (Amsterdam, Netherlands), N. Dijkstra (Amsterdam, Netherlands), P. Bresser (Amsterdam, Netherlands), H. Reesink (Amsterdam, Netherlands)
| |
Evaluation of neutrophil lymphocyte ratio and C-reactive protein values in the treatment of acute chronic obstructive pulmonary disease exacerbation according to endotype
E. Aksoy (Istanbul, Turkey), S. Dadas (Istanbul, Turkey), B. Yilmaz (Istanbul, Turkey), H. Erten (Istanbul, Turkey), M. Hörmet (Istanbul, Turkey), G. Tomas (Istanbul, Turkey), E. Tuncay (Istanbul, Turkey), S. Güngör (Istanbul, Turkey), Ö. Moçin (Istanbul, Turkey), N. Adigüzel (Istanbul, Turkey), G. Güngör (Istanbul, Turkey), Z. Karakurt (Istanbul, Turkey)
| |
COPD mortality after severe exacerbations
I. Bocigas Huescar (Valencia, Spain), L. Fernández Presa (Valencia, Spain), C. Lahosa (Valencia, Spain), C. Gonzalez (Valencia, Spain), J. Carbonell (Valencia, Spain), J. Signes-Costa (Valencia, Spain)
| |
Comparison of FEV1 and BODE INDEX in the assessment of health-related quality of life in patients with COPD
N. Kallel (Sfax, Tunisia), H. Ayedi (Sfax, Tunisia), W. Ketata (Sfax, Tunisia), K. Abdelmouleh (Sfax, Tunisia), S. Kamoun (Sfax, Tunisia)
| |
Which one is superior in predicting 30 and 90 days mortality after COPD exacerbation: DECAF, CURB-65, PSI, DOSE, BAP-65
M. Gayaf (Izmir, Turkey), G. Karadeniz (Izmir, Turkey), F. Güldaval (Izmir, Turkey), G. Polat (Izmir, Turkey), M. Türk (Izmir, Turkey)
| |
Relationship between peak inspiratory flow and handgrip strength measurement in men with mild COPD
Y. Komase (Yokohama, Japan), T. Tsuburai (Yokohama, Japan), S. Tanaka (Yokohama, Japan), B. Ohyama (Yokohama, Japan), H. Muraoka (Yokohama, Japan), N. Hida (Yokohama, Japan), T. Kobayashi (Yokohama, Japan), M. Matsushima (Yokohama, Japan)
| |
Study of heart rate variability in patients with chronic obstructive pulmonary disease
U. Kamilova (Tashkent, Uzbekistan), S. Toshev (Tashkent, Uzbekistan), d. tagaeva (Tashkent, Uzbekistan)
| |
Evaluation Of Vitamin B12 and D, Folic Acid and Homocystein Levels In Stable COPD Patients
M. Turan (Izmir, Turkey), N. Sarioglu (Balikesir, Turkey), P. Turan (IzmirB, Turkey), Ö. Özdemir (IzmirB, Turkey), N. Fazlioglu (Tekirdag, Turkey), M. Köseoglu (Izmir, Turkey), H. Ozkanay (Izmir, Turkey), Ö. Güney (Izmir, Turkey), A. Mirici (Canakkale, Turkey)
| |
Answering questions and challenges in the management of health smoking and COPD patients
E. Uribe Echeverria (CORDOBA, Argentina), S. Vergara (CORDOBA, Argentina), R. Alvarez (CORDOBA, Argentina), A. Nigra (CORDOBA, Argentina), A. Qintar (CORDOBA, Argentina), M. Cristina (CORDOBA, Argentina)
| |
Evaluation of 30 and 90 Day Hospital Readmission Rates in Severe COPD Exacerbations: Turkish Thoracic Society COPD Assembly
M. Polatli (Aydin, Turkey), A. Baha (Kyrenia, Cyprus), N. Kokturk (Ankara, Turkey), D. Yapar (Ankara, Turkey), S. Ozkan (Ankara, Turkey), E. Sen (Ankara, Turkey), F. Ciftci (Ankara, Turkey), B. Ozturk (Ankara, Turkey), S. Kodalak (Ankara, Turkey), G. Ulubay (Ankara, Turkey), I. Serifoglu (Hatay, Turkey), Y. Varol (Izmir, Turkey), A. Mertoglu (Izmir, Turkey), A. Cirak (Izmir, Turkey), O. Turan (Izmir, Turkey), N. Dursunoglu (Denizli, Turkey), N. Savurmus (Denizli, Turkey), A. Gurgun (Izmir, Turkey), F. Elmas (Izmir, Turkey), L. Coplu (Ankara, Turkey), U. Sertcelik (Ankara, Turkey), R. Yildiz (Istanbul, Turkey), I. Ozmen (Istanbul, Turkey), A. Alpaydin (Izmir, Turkey), E. Karacay Yesiloglu (Ankara, Turkey), D. Celik (Ankara, Turkey)
| |
Description of the COPD patients free of suffering severe exacerbations. Ten-year follow up of a cohort
C. Esteban Gonzalez (Galdakao (Bizkaia), Spain), A. Aramburu (Galdakao (Bizkaia), Spain), A. Antón-Ladislao (Galdakao (Bizkaia), Spain), L. Chasco (Galdakao (Bizkaia), Spain), F. Moraza (Galdakao (Bizkaia), Spain), S. Aizpiri (Galdakao (Bizkaia), Spain), M. Gorordo (Galdakao (Bizkaia), Spain), I. Arostegui (Galdakao (Bizkaia), Spain)
| |